(Q39485992)

12 September 2017

title

Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity (English)

1 reference

12 September 2017

1 reference

Abraha Habtemariam

2

0 references

author name string

Ying Fu

1

1 reference

12 September 2017

Aida M B H Basri

3

1 reference

12 September 2017

Darren Braddick

4

1 reference

12 September 2017

Guy J Clarkson

5

1 reference

12 September 2017

Peter J Sadler

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

22 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

40

1 reference

12 September 2017

issue

40

1 reference

12 September 2017

page(s)

10553-10562

1 reference

Platinum Compounds: a New Class of Potent Antitumour Agents

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Bioorganometallic chemistry--from teaching paradigms to medicinal applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Organometallic anticancer compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Inhibition of cancer cell growth by ruthenium(II) arene complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Osmium carbonyl clusters containing labile ligands hyperstabilize microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Ruthenium- and Osmium-Arene Complexes of 2-Substituted Indolo[3,2-c]quinolines: Synthesis, Structure, Spectroscopic Properties, and Antiproliferative Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Osmium(VI) complexes as a new class of potential anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Osmium carbonyl clusters: a new class of apoptosis inducing agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Osmium NAMI-A analogues: synthesis, structural and spectroscopic characterization, and antiproliferative properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Intra-articular osmic acid in rheumatoid arthritis: five years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Is there a place for chemical and radiation synovectomy in rheumatic diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Organometallic osmium arene complexes with potent cancer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Anti-colorectal cancer activity of an organometallic osmium arene azopyridine complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Catalytic organometallic anticancer complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Molecular properties that influence the oral bioavailability of drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Bioisosterism: A Rational Approach in Drug Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Fluorescence probes used for detection of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

The nature of .pi.-.pi. interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

DNA Interactions of Monofunctional Organometallic Ruthenium(II) Antitumor Complexes in Cell-free Media

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Arene control over thiolate to sulfinate oxidation in albumin by organometallic ruthenium anticancer complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Cisplatin: mode of cytotoxic action and molecular basis of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Interactions with aromatic rings in chemical and biological recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and anti

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Cytoplasmic initiation of cisplatin cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Phase annealing in SHELX-90: direct methods for larger structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Sulforhodamine B colorimetric assay for cytotoxicity screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

Calculation of the Hydrophobicity of Platinum Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1DT10937E

21 January 2018

Identifiers

DOI

10.1039/C1DT10937E

1 reference

12 September 2017

1 reference